Study Suggests UC-II® Relieves Pain in Arthritic Dogs

Study Suggests UC-II® Relieves Pain in Arthritic Dogs Study presented at the annual meeting of the Society of Toxicology indicates that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Study Shows Fish Oil to be Safe and Effective for Neck and Back Conditions Study published in the April 2006 issue of Surgical Neurology involved 250 patients under physician’s care, most of whom suffered from degenerative disc conditions, providing subjects with 2 or 4 ProEPA capsules a day. After an average of 75 days of fish oil supplementation, 60% of respondents reported significant improvements, including reduction in overall pain and 59% were able to stop taking other pain medicine. Study Shows Fish Oil to be Safe and Effective for Neck and Back Conditions Study published in the April 2006 issue of Surgical Neurology involved 250 patients under physician’s care, most of whom suffered from degenerative disc conditions, providing subjects with 2 or 4 ProEPA capsules a day. After an average of 75 days of fish oil supplementation, 60% of respondents reported significant improvements, including reduction in overall pain and 59% were able to stop taking other pain medicine. Study Shows Fish Oil to be Safe and Effective for Neck and Back Conditions Study published in the April 2006 issue of Surgical Neurology involved 250 patients under physician’s care, most of whom suffered from degenerative disc conditions, providing subjects with 2 or 4 ProEPA capsules a day. After an average of 75 days of fish oil supplementation, 60% of respondents reported significant improvements, including reduction in overall pain and 59% were able to stop taking other pain medicine. Study Shows Fish Oil to be Safe and Effective for Neck and Back Conditions Study published in the April 2006 issue of Surgical Neurology involved 250 patients under physician’s care, most of whom suffered from degenerative disc conditions, providing subjects with 2 or 4 ProEPA capsules a day. After an average of 75 days of fish oil supplementation, 60% of respondents reported significant improvements, including reduction in overall pain and 59% were able to stop taking other pain medicine. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Indicates Multiple Mechanisms Involved In The Inhibition Of The Growth Of LNCaP Prostate Cancer Cells By Plant Lignans Research performed by the Department of Clinical Medicine at the University of Insubria in Italy has shed further light into the mechanisms involved in the inhibition of the growth of LNCaP prostate cancer cells by plant lignans; LNCaP cells lines were incubated with either enterolactone (70-100 microMols) or hydroxymatairesinol (70-100 microMols) for 48 hours, with estradiol (100 microMols) and the cytotoxic agent cycloheximide (10 microMols) used as the experimental controls, with results showing a concentration-dependent increase in the proportion of apoptotic cells for both substances -- enterolactone was about two-fold as effective as hydroxymatairesinol in this experiment but less than half that of cycloheximide and estradiol. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. New Study Shows Cinnamon Lowers Blood Pressure and Improves Insulin Function Placebo-controlled, double-blind study from Georgetown University in this month’s Journal of the American College of Nutrition indicates that rats taking whole cinnamon or cinnamon extract showed decreased systolic blood pressure and improved insulin function, with the extract group lowering circulating levels of fructosamine and the whole cinnamon group lowering circulating insulin concentrations. Study Confirms UroLogic(TM) Effectively Reduces Symptoms of Overactive Bladder and Urinary Incontinence Two-month randomized, double blind, placebo controlled trial of 73 men and women ages 29 88 years revealed that 85 percent of participants receiving UroLogic demonstrated significant reduction in symptoms including frequency of urination and/or incidence of leakage after two months, with 70 percent of those in the UroLogic group noting an increase in their quality of life. Study Confirms UroLogic(TM) Effectively Reduces Symptoms of Overactive Bladder and Urinary Incontinence Two-month randomized, double blind, placebo controlled trial of 73 men and women ages 29 88 years revealed that 85 percent of participants receiving UroLogic demonstrated significant reduction in symptoms including frequency of urination and/or incidence of leakage after two months, with 70 percent of those in the UroLogic group noting an increase in their quality of life. Study Confirms UroLogic(TM) Effectively Reduces Symptoms of Overactive Bladder and Urinary Incontinence Two-month randomized, double blind, placebo controlled trial of 73 men and women ages 29 88 years revealed that 85 percent of participants receiving UroLogic demonstrated significant reduction in symptoms including frequency of urination and/or incidence of leakage after two months, with 70 percent of those in the UroLogic group noting an increase in their quality of life. Study Confirms UroLogic(TM) Effectively Reduces Symptoms of Overactive Bladder and Urinary Incontinence Two-month randomized, double blind, placebo controlled trial of 73 men and women ages 29 88 years revealed that 85 percent of participants receiving UroLogic demonstrated significant reduction in symptoms including frequency of urination and/or incidence of leakage after two months, with 70 percent of those in the UroLogic group noting an increase in their quality of life. Double-Blind Study Examines Tolerability of Ester-C Double-blind study, published in a recent issue of Advances in Natural Therapy(R), showed that the Ester formulation of vitamin C caused significantly fewer adverse epigastric effects (stomach upsets) and was much better tolerated by the body compared to regular vitamin C. Double-Blind Study Examines Tolerability of Ester-C Double-blind study, published in a recent issue of Advances in Natural Therapy(R), showed that the Ester formulation of vitamin C caused significantly fewer adverse epigastric effects (stomach upsets) and was much better tolerated by the body compared to regular vitamin C. Double-Blind Study Examines Tolerability of Ester-C Double-blind study, published in a recent issue of Advances in Natural Therapy(R), showed that the Ester formulation of vitamin C caused significantly fewer adverse epigastric effects (stomach upsets) and was much better tolerated by the body compared to regular vitamin C. Double-Blind Study Examines Tolerability of Ester-C Double-blind study, published in a recent issue of Advances in Natural Therapy(R), showed that the Ester formulation of vitamin C caused significantly fewer adverse epigastric effects (stomach upsets) and was much better tolerated by the body compared to regular vitamin C. Neptune Announces Study Results of NKO(TM) – Statin Combination The study, entitled “Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia”, was conducted by McGill University and University of Montreal affiliated doctors, to assess the effects of Neptune Krill Oil on total cholesterol, triglycerides, LDL and HDL compared to Statins, fish oil and placebo. Neptune Announces Study Results of NKO(TM) – Statin Combination The study, entitled “Evaluation of the effects of Neptune Krill Oil on the clinical course of hyperlipidemia”, was conducted by McGill University and University of Montreal affiliated doctors, to assess the effects of Neptune Krill Oil on total cholesterol, triglycerides, LDL and HDL compared to Statins, fish oil and placebo. The Hershey Company Establishes Center for Health and Nutrition and Releases Study Results Linking Cocoa to Improved Cardiovascular Function Company announces the establishment of the Hershey Center for Health and Nutrition, to direct scientific research to develop products and technologies providing consumers with health benefits in the areas of heart health, weight management, and mental and physical energy. The Hershey Company Establishes Center for Health and Nutrition and Releases Study Results Linking Cocoa to Improved Cardiovascular Function Company announces the establishment of the Hershey Center for Health and Nutrition, to direct scientific research to develop products and technologies providing consumers with health benefits in the areas of heart health, weight management, and mental and physical energy. The Hershey Company Establishes Center for Health and Nutrition and Releases Study Results Linking Cocoa to Improved Cardiovascular Function Company announces the establishment of the Hershey Center for Health and Nutrition, to direct scientific research to develop products and technologies providing consumers with health benefits in the areas of heart health, weight management, and mental and physical energy. The Hershey Company Establishes Center for Health and Nutrition and Releases Study Results Linking Cocoa to Improved Cardiovascular Function Company announces the establishment of the Hershey Center for Health and Nutrition, to direct scientific research to develop products and technologies providing consumers with health benefits in the areas of heart health, weight management, and mental and physical energy. EcoNugenics Announces New Meta-Analysis on Peripheral Arterial Disease A meta-analysis of 19 published clinical trials on Padma Basic®, a Tibetan herbal formula, has concluded that the preparation is safe and effective in providing significant relief for a common vascular condition - peripheral arterial disease (PAD). EcoNugenics Announces New Meta-Analysis on Peripheral Arterial Disease A meta-analysis of 19 published clinical trials on Padma Basic®, a Tibetan herbal formula, has concluded that the preparation is safe and effective in providing significant relief for a common vascular condition - peripheral arterial disease (PAD). EcoNugenics Announces New Meta-Analysis on Peripheral Arterial Disease A meta-analysis of 19 published clinical trials on Padma Basic®, a Tibetan herbal formula, has concluded that the preparation is safe and effective in providing significant relief for a common vascular condition - peripheral arterial disease (PAD). EcoNugenics Announces New Meta-Analysis on Peripheral Arterial Disease A meta-analysis of 19 published clinical trials on Padma Basic®, a Tibetan herbal formula, has concluded that the preparation is safe and effective in providing significant relief for a common vascular condition - peripheral arterial disease (PAD). Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Broccoli, Cauliflower and Genetic Cancer New study on a mouse model, at Rutgers shows that certain vegetables – broccoli and cauliflower, in particular – have natural ingredients including sulforaphane that may reduce the risk of developing hereditary cancers. Lipid Nutrition presents New Research on Clarinol(TM) CLA at DDW 2006 research shows that Clarinol™ CLA reduces fat mass in particular locations on the body, without any additional exercise, as subjects in placebo-controlled randmoized trial lost 2 kg of fat (equal to 4.4 lbs.) around the waist area and in the legs. Lipid Nutrition presents New Research on Clarinol(TM) CLA at DDW 2006 research shows that Clarinol™ CLA reduces fat mass in particular locations on the body, without any additional exercise, as subjects in placebo-controlled randmoized trial lost 2 kg of fat (equal to 4.4 lbs.) around the waist area and in the legs. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Report of the Independent Vitamin Safety Review Panel A recent US National Institutes of Health report has attempted to cast doubt on food supplement safety. The opinion offered the Independent Vitamin Safety Review Panel observes that 1) the NIH report is biased against nutritional supplementation, because 2) NIH’s selection of panel members excluded professionals that advocate nutritional supplementation, and 3) the research NIH reviewed selectively excluded hundreds of studies supporting the safety and effectiveness of nutritional supplementation. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. Solazyme Announces New Vice President of Research and Development Algal biotechnology company announces that it has named Dr. Anthony (Tony) G. Day to the position of Vice President of Research and Development of the Company. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. New Study Finds Key Role for Collagen Hydrolysate in Managing Chronic Joint Symptoms Results from a postmarketing surveillance study with adult athletes at the German Olympic Center in Essen, Germany to be presented at the upcoming meeting of the American College of Sports Medicine found that during a 12-week(3) study period, 79 percent of the study's participants had statistically significant improvement in joint mobility and flexibility after a course of 10g per day of CH-Alpha(TM), a supplement containing collagen hydrolysate. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. Herbal Remedy Could Help Sufferers of Type 2 Diabetes British researchers, in a placebo controlled study on 79 subjects, set out to see if patients with type 2 diabetes, consuming a western diet and taking prescribed medication with daily hawthorn extract would show greater hypotensive effects over 16 weeks than a placebo group. The researhcers observed that those taking the hawthorn, after a 16 week period, had a significant reduction of 2.6 mmHg in their diastolic blood pressure. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	Study Found Adding UC-II to Glucosamine and Chondroitin Also More Effective in Relieving Pain than Glucosamine and Chondroitin Alone BENICIA, Calif., May 17, 2006 – A new study shows that UC-II®, an undenatured or intact form of type II collagen found in the cartilage of bone joints, is more than twice as effective in decreasing pain in osteoarthritic dogs than glucosamine and chondroitin alone. UC-II in combination with glucosamine and chondroitin was also more than twice as effective in reducing pain and increasing joint flexibility and activity than glucosamine and chondroitin alone. UC-II, a patented ingredient produced by InterHealth Nutraceuticals, Inc., has previously been shown to improve joint flexibility and reduce arthritic symptoms in humans. This new study, conducted on osteoarthritic dogs at Murray State University in Kentucky and presented at the annual meeting of the Society of Toxicology in March 2006 in San Diego, showed that UC-II taken alone reduced overall pain by 62%, while painful limb movement and lameness decreased by 91% and 78%, respectively. UC-II plus glucosamine and chondroitin reduced overall pain in the subjects by 57%, and pain with limb movement and lameness each by 53%, compared to only 24%, 29% and 39%, respectively, in dogs taking the glucosamine and chondroitin combination without UC-II. No adverse effects or changes in liver, heart or kidney functions were observed in any of the animals included in the study. In addition to the earlier human clinical research, a study published last year in the Journal of Veterinary Pharmacological and Therapeutics showed that UC-II had reduced pain and lameness in arthritic dogs. Furthermore, UC-II improved the overall activity of the dogs. “The results of this new study provide further proof of UC-II’s benefits for anyone seeking relief from joint problems – for themselves or for their companion animals,” said Manashi Bagchi, Ph.D., senior scientist with InterHealth. “And for individuals who may want to include glucosamine and chondroitin in their supplement use, or in supplements for their pets, this study shows that adding UC-II to their daily regimen can make a significant difference in relieving pain and stiffness and improving their quality of life,” she added. “Manufacturers and retailers now have new options to offer consumers who are looking for a safe and effective product for bone and joint health,” said Paul Dijkstra, executive vice president at InterHealth. “Consumers can enjoy the benefits of UC-II alone or in combination with glucosamine and chondroitin, knowing that they will have an effective product and that neither alternative will produce the serious side effects that often come with prescription products or with over-the-counter pain-relievers such as non-steroidal anti-inflammatory drugs.” Dijkstra added that UC-II has yet another advantage for health-conscious consumers. “The dosage for UC-II is only 40 mg.,” he said. “For people who may have difficulty in swallowing larger pills, this small size means that even when UC-II is combined with other ingredients the final product will still be of manageable size.” Strong Market for Natural Bone and Joint Health Products A 2005 consumer survey by the Natural Marketing Institute shows that even relatively young consumers have concerns about bone and joint health, and are willing to consider natural remedies for these problems. Among the general population, 71% are concerned about preventing arthritis or joint disease and 41% say they or a household member is currently managing joint pain or stiffness. And after age 35, arthritis and joint disease is one of six conditions of high concern. Lastly, arthritis and joint disease is the number one condition that consumers say they would treat (68%) or prevent (69%) with supplements. # # # About InterHealth Nutraceuticals Inc. InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. In addition to UC-II, the company’s products include Super CitriMax®, ChromeMate®, Aller-7®, OptiBerry®, L-OptiZinc® and Protykin®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit the website at www.InterHealthUSA.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software